Overview

Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the relationship of pCR rate and efficacy by comparing the two drugs and three drugs as neoadjuvant chemotherapy in advanced gastric cancer patients.
Phase:
Phase 3
Details
Lead Sponsor:
Qun Zhao
Collaborator:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Capecitabine
Docetaxel
Oxaliplatin